Woman Denied Bank Transaction Because Chemo Erased Her Fingerprints

The woman had something called hand-foot syndrome.

"She was distressed because she went to do the procedure with the bank and also because she was planning to travel to Europe and, you know, in the border we need to use our fingerprints," said the woman's oncologist, Dr. Yanin Chavarri-Guerra, who authored the study. "Those things were stressing her."

During the patient's first round of chemotherapy, her hand-foot syndrome was mild, according to the study. During the third round, the hand-foot syndrome symptoms worsened, and she had to limit personal care activities.

Anywhere from 45 to 68.3 percent of people on the chemotherapy drug capecitabine develop hand-foot syndrome, according to an article published in the Cancer Investigation Journal in 2002. It's not clear how many of those people lose their fingerprints.

Chavarri-Guerra said she doesn't know whether her patient's fingerprints returned, but she said the woman is cancer-free, no longer on chemotherapy and pain-free.

Dr. Kate Sully, a resident in the ABC News Medical Unit, contributed to this report.